Literature DB >> 18449595

Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review.

Gaurav Agarwal1, Vivek Aggarwal.   

Abstract

BACKGROUND: Benign multinodular goiter is one of the most common endocrine surgical problems. The appropriate surgical procedure for its effective and safe management is a matter of debate. Though seen by some as an overly hazardous procedure because of the risk of recurrent laryngeal nerve injury and damage to parathyroid function, total thyroidectomy has replaced subtotal thyroidectomy as the procedure of choice, as the latter is associated with significant recurrences.
METHODS: A systemic literature review was undertaken of all available medical literature to evaluate whether total thyroidectomy is the appropriate, safe and effective surgical procedure for benign multinodular goiter.
RESULTS: There is consistent level II-IV evidence that subtotal thyroidectomy results in recurrence in up to 50% patients. Incidental thyroid cancers are detected in 3%-16.6% of apparently benign goiters in numerous studies, mostly providing level IV evidence, one third of which would need further surgical treatment after subtotal thyroidectomy. Studies comparing subtotal thyroidectomy and total thyroidectomy, including two each of prospective randomized and prospective nonrandomized ones, provide level II-IV evidence that permanent complication rates associated with subtotal thyroidectomy and total thyroidectomy are not different, although the rate of transient hypocalcemia is higher with total thyroidectomy. On basis of these findings, a grade B recommendation can be made that subtotal thyroidectomy is associated with significant recurrence of goiter, leaves a small number of incidentally detected thyroid cancers inadequately treated, and provides little significant safety advantage over total thyroidectomy. Grade C recommendations can also be made about total thyroidectomy being a safe and effective procedure for benign multinodular goiters in the hands of expert surgeons, based on the extensive level IV evidence, and limited level II and level III evidence, which show that the risk of permanent vocal cord palsy and hypoparathyroidism associated with total thyroidectomy is below the acceptable 2% rate, but not without exceptions.
CONCLUSION: Total thyroidectomy is the procedure of choice for the surgical management of benign multinodular goiter.

Entities:  

Mesh:

Year:  2008        PMID: 18449595     DOI: 10.1007/s00268-008-9579-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  49 in total

1.  Total thyroidectomy: the evolution of surgical technique.

Authors:  Leigh Delbridge
Journal:  ANZ J Surg       Date:  2003-09       Impact factor: 1.872

2.  [Development and outcomes of the surgical management of multinodular goiter].

Authors:  Angel Gómez Palacios; M Teresa Gutiérrez; Jesús Gómez; Miguel Angel Taibo; Jesús Gómez Zabala; Borja Barrios; Antonio Escobar; Iñaki Iturburu
Journal:  Cir Esp       Date:  2006-08       Impact factor: 1.653

3.  Safety and efficacy of total thyroidectomy in hands of endocrine surgery trainees.

Authors:  A Mishra; G Agarwal; A Agarwal; S K Mishra
Journal:  Am J Surg       Date:  1999-11       Impact factor: 2.565

4.  Comparison of surgical techniques for treatment of benign toxic multinodular goiter.

Authors:  Orhan Alimoglu; Murat Akdag; Mustafa Sahin; Cagatay Korkut; Ismail Okan; Neslihan Kurtulmus
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  A randomized prospective study of complications between general surgery residents and attending surgeons in near-total thyroidectomies.

Authors:  Zeki Acun; Alper Cihan; Suat Can Ulukent; Mustafa Comert; Bulent Ucan; Guldeniz Karadeniz Cakmak; Ali Cesur
Journal:  Surg Today       Date:  2004       Impact factor: 2.549

6.  Recurrence after total thyroidectomy for benign multinodular goiter.

Authors:  Kylie L Snook; Peter L H Stalberg; Stan B Sidhu; Mark S Sywak; Pamela Edhouse; Leigh Delbridge
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

7.  [Is primary total thyroidectomy justified in benign multinodular goiter? Results of a prospective quality assurance study of 45 hospitals offering different levels of care].

Authors:  O Thomusch; C Sekulla; H Dralle
Journal:  Chirurg       Date:  2003-05       Impact factor: 0.955

8.  Can total thyroidectomy be performed as safely by general surgeons in provincial centers as by surgeons in specialized endocrine surgical units? Making the case for surgical training.

Authors:  T S Reeve; A Curtin; L Fingleton; P Kennedy; W Mackie; T Porter; D Simons; D Townend; L Delbridge
Journal:  Arch Surg       Date:  1994-08

9.  [Non-toxic multinodular goitre: which surgery?].

Authors:  G Scerrino; G Salamone; M A Farulla; G Romano; S Salamone; G Pompei; G Buscemi
Journal:  Ann Ital Chir       Date:  2001 Nov-Dec       Impact factor: 0.766

10.  Surgical treatment of multinodular goiter in young patients.

Authors:  Antonio Ríos; José M Rodríguez; Pedro J Galindo; Mariano J Montoya; Manuel Canteras; Pascual Parrilla
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

View more
  56 in total

Review 1.  State of the art: surgery for endemic goiter--a plea for individualizing the extent of resection instead of heading for routine total thyroidectomy.

Authors:  Henning Dralle; Kerstin Lorenz; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2011-06-01       Impact factor: 3.445

2.  State of the art: surgery for endemic goiter.

Authors:  P V Pradeep
Journal:  Langenbecks Arch Surg       Date:  2011-11-15       Impact factor: 3.445

3.  Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter.

Authors:  Marcin Barczyński; Aleksander Konturek; Alicja Hubalewska-Dydejczyk; Filip Gołkowski; Stanisław Cichoń; Wojciech Nowak
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 4.  [Identification of the recurrent laryngeal nerve and parathyroids in thyroid surgery].

Authors:  H Dralle
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

5.  Completion thyroidectomy in differentiated thyroid cancer: When to perform?

Authors:  Abdullah Kısaoğlu; Bünyami Özoğul; Müfide Nuran Akçay; Gürkan Öztürk; Sabri Selçuk Atamanalp; Bülent Aydınlı; Salih Kara
Journal:  Ulus Cerrahi Derg       Date:  2014-03-01

6.  Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).

Authors:  L Rosato; C De Crea; R Bellantone; M L Brandi; G De Toma; S Filetti; P Miccoli; F Pacini; M R Pelizzo; A Pontecorvi; N Avenia; L De Pasquale; M G Chiofalo; A Gurrado; N Innaro; G La Valle; C P Lombardi; P L Marini; G Mondini; B Mullineris; L Pezzullo; M Raffaelli; M Testini; M De Palma
Journal:  J Endocrinol Invest       Date:  2016-04-08       Impact factor: 4.256

7.  Outcomes of Capsular Dissection Technique with Use of Bipolar Electrocautery in Total Thyroidectomy: A Rural Tertiary Center Experience.

Authors:  Amal T Das; S B Prakash; V Priyadarshini
Journal:  J Clin Diagn Res       Date:  2016-12-01

8.  Assessment of swallowing function impairment in patients with benign goiters and impact of thyroidectomy: a case control study.

Authors:  Mayilvaganan Sabaretnam; Anjali Mishra; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

9.  Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer.

Authors:  Gabriel Glockzin; Matthias Hornung; Klaus Kienle; Katrin Thelen; Marita Boin; Andreas G Schreyer; Hamid R Lighvani; Hans J Schlitt; Ayman Agha
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

10.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.